(Q26852113)

Margarete Focke-Tejkl

series ordinal

2

1 reference

Christian Lupinek

series ordinal

3

1 reference

Verena Niederberger

series ordinal

5

1 reference

publication date

2014

1 reference

Current treatment options in allergy

published in

1 reference

volume

1

1 reference

page(s)

91-106

1 reference

Creative Commons Attribution 2.0 Generic

copyright license

start time

26 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Safety of engineered allergen-specific immunotherapy vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Recombinant allergens: the present and the future

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Immunological mechanisms of allergen-specific immunotherapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

An assay that may predict the development of IgG enhancing allergen-specific IgE binding during birch immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Expression of hypoallergenic Der f 2 derivatives with altered intramolecular disulphide bonds induces the formation of novel ER-derived protein bodies in transgenic rice seeds

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Allergen-specific immunotherapy: towards combination vaccines for allergic and infectious diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

T cell epitope-based allergy vaccines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Vaccine approaches for food allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Seed-based oral vaccines as allergen-specific immunotherapies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Recombinant Bet v 1 vaccine for treatment of allergy to birch pollen.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

From allergen genes to allergy vaccines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Food allergen protein families and their structural characteristics and application in component-resolved diagnosis: new data from the EuroPrevall project

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Allergens are distributed into few protein families and possess a restricted number of biochemical functions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Cross-reactivity of pollen allergens: impact on allergen immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Molecular approaches for new vaccines against allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Transition from a botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Vaccination with genetically engineered allergens prevents progression of allergic disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Vaccine engineering improved by hybrid technology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Renaissance of the blocking antibody concept in type I allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Microarrayed recombinant allergens for diagnosis of allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Long-term clinical efficacy of grass-pollen immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Immunological and structural similarities among allergens: prerequisite for a specific and component-based therapy of allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Bacterial 16S ribosomal DNA in house dust mite cultures.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Molecular composition and biological activity of commercial birch pollen allergen extracts.

31 May 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Allergen content and in vivo allergenic activity of house dust mite extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Endotoxin content of standardized allergen vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalv

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Transgenic rice seeds accumulating recombinant hypoallergenic birch pollen allergen Bet v 1 generate giant protein bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Intranasal, liposome-adjuvanted cockroach allergy vaccines made of refined major allergen and whole-body extract of Periplaneta americana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Monitoring honeybee venom immunotherapy in children with the basophil activation test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Natural course of sensitization to food and inhalant allergens during the first 6 years of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Critical Role of Preconceptional Immunization for Protective and Nonpathological Specific Immunity in Murine Neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Early life interventions to prevent allergy in the offspring: the role of maternal immunization and postnatal mucosal allergen exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Cytokine and Antibody Responses in Birch-Pollen-Allergic Patients Treated with Genetically Modified Derivatives of the Major Birch Pollen Allergen Bet v 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Non–IgE-mediated chronic allergic skin inflammation revealed with rBet v 1 fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40521-013-0006-5

Allergen microarray detects high prevalence of asymptomatic IgE sensitizations to tropical pollen-derived carbohydrates

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025905

Skin prick test extracts for dog allergy diagnosis show considerable variations regarding the content of major and minor dog allergens

28 November 2018

1 reference

12 December 2020

Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation

1 reference

12 December 2020

Treatment of cat allergy with T-cell reactive peptides

1 reference

12 December 2020

Effect of maternal immunotherapy on immediate skin test reactivity, specific rye I IgG and IgE antibody, and total IgE of the children

1 reference

12 December 2020

Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy-treated mother

1 reference

12 December 2020

Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System

1 reference

12 December 2020

Allergen-specific immunotherapy with recombinant grass pollen allergens

1 reference

12 December 2020

Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial

1 reference

12 December 2020

False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens☆☆☆★★★

1 reference

12 December 2020

Epicutaneous Immunotherapy Results in Rapid Allergen Uptake by Dendritic Cells through Intact Skin and Downregulates the Allergen-Specific Response in Sensitized Mice

1 reference

12 December 2020

Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression

1 reference

12 December 2020

A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy

1 reference

12 December 2020

Recombinant allergens for specific immunotherapy

1 reference

12 December 2020

Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity

1 reference

12 December 2020

Vaccination with transgenic rice seed expressing mite allergen: a new option for asthma sufferers?

1 reference

12 December 2020

Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial

1 reference

12 December 2020

Heterogeneity of commercial timothy grass pollen extracts

1 reference

12 December 2020

Characterization and comparison of commercially available mite extracts for in vivo diagnosis

1 reference

12 December 2020

10.1007/S40521-013-0006-5

Identifiers

DOI

1 reference

Dimensions Publication ID

1041686191

0 references

1 reference

1 reference

PubMed publication ID

24860720

1 reference